Previously called Icogen Corporation, Icogenex is using ICOCEPTTM, its platform technology, to identify therapeutically useful molecules for the treatment of inflammatory diseases, Alzheimer's disease, and diseases involving inappropriate proteolytic processing.proven capabilities in expressing proteins from bacteria, yeast and mammalian cells. With proven capabilities in expressing proteins from bacteria, yeast and mammalian cell., the company partners with pharmaceutical companies, provides contract research services and leverages in-house drug development projects to express therapeutic proteins.
